Pneumococcal conjugate vaccines for preventing invasive pneumococcal disease and pneumonia in children aged up to five years

This publication has 22 references indexed in Scilit:

• Cochrane Handbook for Systematic Reviews of Interventions
  2019
• Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals
  The Lancet, 2016
• The economic burden of childhood invasive pneumococcal diseases and pneumonia in Taiwan: Implications for a pneumococcal vaccination program
  Human Vaccines & Immunotherapeutics, 2015
• Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage
  The Pediatric Infectious Disease Journal, 2014
• Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Invasive Pneumococcal Disease Among Young Children
  The Pediatric Infectious Disease Journal, 2014
• Healthcare utilization and cost of pneumococcal disease in the United States
  Vaccine, 2011
• Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project
  PLOS Medicine, 2010
• Recommendations for the Prevention of Streptococcus pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)
  Pediatrics, 2010
• Grading quality of evidence and strength of recommendations
  BMJ, 2004
• Vaccination and the respiratory tract - what should we know?
  Jornal de Pediatria, 2002